MARKET

SNYNF

SNYNF

Sanofi FR
OTCPK
88.50
NaN%
Opening 09:30 07/01 EDT
OPEN
--
PREV CLOSE
88.50
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
100.10
52 WEEK LOW
85.42
MARKET CAP
106.22B
P/E (TTM)
21.06
1D
5D
1M
3M
1Y
5Y
1D
AI Daily: Amazon’s AWS commits $1B toward new unit
TipRanks · 1d ago
Anthropic takes aim at pharma industry with Claude Science, STAT reports
TipRanks · 1d ago
Vertex Pharmaceuticals Has One Of The Widest And Most Durable Moats In Biotech
Seeking Alpha · 1d ago
TG Therapeutics Surged 88%: Time To Be More Careful (Rating Downgrade)
Seeking Alpha · 2d ago
Weekly Report: what happened at SNYNF last week (0622-0626)?
Weekly Report · 2d ago
Sanofi: Dupixent Risks Overstated, Valuation Disconnect Creates Opportunity
Seeking Alpha · 6d ago
MacroGenics: 'Hold' Potential Best-In-Class B7-H3 ADC And TZIELD Payment
Seeking Alpha · 06/24 18:35
Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) Advances Novel Multiple Sclerosis Therapy Toward Phase 2 Trials
TipRanks · 06/23 18:35
More
About SNYNF
Sanofi SA is a France-based healthcare company based in France. The Company focuses on patient needs and engages in the research, development, manufacture, and marketing of therapeutic solutions. Its three operating segments are: Pharmaceuticals, Consumer Healthcare (CHC), and Vaccines. The Pharmaceuticals includes: Immunology, Multiple Sclerosis / Neurology, Oncology, Rare Diseases, Rare Blood Disorders, Cardiovascular, Diabetes, Established Prescription Products. The Vaccines segment comprises, for all geographical territories, the commercial operations of Sanofi Pasteur, together with research, development, and production activities dedicated to vaccines. The CHC segment comprises the commercial operations for Sanofi’s Consumer Healthcare products, together with research, development and production activities dedicated to those products. The Company’s products developed in collaboration or franchise include Dupixent, Aubagio, Lemtrada, Cerezyme, Lumizyme, Jevtana, Fabrazyme.

Webull offers Sanofi SA stock information, including OTCPK: SNYNF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SNYNF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SNYNF stock methods without spending real money on the virtual paper trading platform.